Six Questions For McKinsey Executives On Pharma’s Digital Experience
McKinsey & Co executives Vikas Bhadoria and Parag Patel, in an interview with Scrip, shared some key insights into pharma’s recent efforts around digitization and advanced analytics including the emergence of a Bayer site as a manufacturing ‘lighthouse’, Novartis’ Nerve Live platform and sales rep versus digital channel effectiveness.
You may also be interested in...
Cipla’s global COO Dr R Ananthanarayanan tells Scrip how the company is rethinking and refining its manufacturing operations in the backdrop of intense competition and evolving customer and regulatory requirements. Digitization and advanced analytics are part of the proposed manufacturing innovation plans.
Abbott’s new digital initiative in India, which already has 2,000 physicians and 1,000 patients on board, aims to provide services and information to improve health outcomes. Gamification concepts and an offline component such as a learning program for physicians are also part of the new offering.
Eris Lifesciences has acquired a Novartis trademark for vildagliptin, a DPP-4 inhibitor that has been the subject of a torrent of alleged infringement-related legal action in India. Pricing for the acquired brand will be interesting to watch from now on as a patent on vildagliptin is set to expire soon.